HBM Healthcare Investments (Cayman) Ltd.

Insider Reports History

Location
Grand Cayman, Cayman Islands
Signature
/s/ Jean-Marc LeSieur, Managing Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by HBM Healthcare Investments (Cayman) Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. 10%+ Owner Common Stock 3,218,106 $19,199,542 $5.97 14 Feb 2023 Direct
IO Biotech, Inc. 10%+ Owner Common Stock 2,690,545 $2,784,714 $1.04 09 Nov 2021 Direct
IO Biotech, Inc. 10%+ Owner Series C Preferred Stock 0 09 Nov 2021 Direct
Mineralys Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 14 Feb 2023 Direct
Mineralys Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 14 Feb 2023 Direct

Insider Reports Filed by HBM Healthcare Investments (Cayman) Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MLYS Mineralys Therapeutics, Inc. 14 Feb 2023 5 +$5,000,000 4 10%+ Owner 16 Feb 2023, 20:00
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 0 $0 3 10%+ Owner 09 Feb 2023, 20:04
IOBT IO Biotech, Inc. 09 Nov 2021 3 +$4,550,000 4 10%+ Owner 12 Nov 2021, 15:16
IOBT IO Biotech, Inc. 04 Nov 2021 0 $0 3 10%+ Owner 04 Nov 2021, 21:36